Apalutamide for prostate cancer: Multicentre and multidisciplinary real‐world study of 227 patients

Abstract Objective To evaluate the efficacy and safety of apalutamide prostate cancer compared to the pivotal trials patients and to identify the first subsequent therapy in a real‐world setting. Methods The study is prospective and observational based on real‐world evidence, performed by different...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Julián Córdoba Sánchez, Natalia Picola, Alejo Rodriguez‐Vida, Marc Costa, David Marmolejo Castañeda, Meritxell Pérez Márquez, Jesús Muñoz Rodriguez, J. M. Gaya, Alejandra Bravo, Oscar Buisan, Pol Servian, Jose Francisco Suarez, Mireia Musquera Felip, Maria Jose Ribal Caparrós, Antonio Alcaraz Asensio, Antoni Vilaseca
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Wiley 2023-12-01
Sarja:	Cancer Medicine
Aiheet:	apalutamide high‐risk non‐metastatic castration‐resistant prostate cancer metastatic hormone‐sensitive prostate cancer prostate cancer real‐world
Linkit:	https://doi.org/10.1002/cam4.6769
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!